We are live on ! Find out more
INVA icon

Innoviva

200 hedge funds and large institutions have $1.09B invested in Innoviva in 2017 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 77 increasing their positions, 66 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more call options, than puts

Call options by funds: $6.02M | Put options by funds: $4.66M

17% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 66

7% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 27

0% more funds holding

Funds holding: 200200 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

5% less capital invested

Capital invested by funds: $1.14B → $1.09B (-$55.8M)

3.12% less ownership

Funds ownership: 74.01%70.89% (-3.1%)

Holders
200
Holders Change
Holders Change %
0%
% of All Funds
4.54%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
29
Increased
77
Reduced
66
Closed
27
Calls
$6.02M
Puts
$4.66M
Net Calls
+$1.36M
Net Calls Change
-$615K
Name Holding Trade Value Shares
Change
Change in
Stake
American Century Companies
26
American Century Companies
Missouri
$8.11M -$207K -15,492 -3%
CEP
27
Chicago Equity Partners
Illinois
$8M +$479K +35,950 +7%
Norges Bank
28
Norges Bank
Norway
$7.98M
GAM
29
Gotham Asset Management
New York
$7.84M -$484K -36,312 -6%
NI
30
Numeric Investors
Massachusetts
$7.2M +$4.27M +320,500 +171%
Acadian Asset Management
31
Acadian Asset Management
Massachusetts
$7.13M +$57.2K +4,289 +0.9%
SIM
32
Spark Investment Management
New York
$6.71M -$899K -67,400 -12%
Wellington Management Group
33
Wellington Management Group
Massachusetts
$6.65M -$1.22M -91,675 -16%
JP Morgan Chase
34
JP Morgan Chase
New York
$6.01M -$4.76M -356,916 -46%
Charles Schwab
35
Charles Schwab
California
$5.94M +$930K +69,750 +20%
BGIM
36
Brandywine Global Investment Management
Pennsylvania
$5.5M +$256K +19,189 +5%
T. Rowe Price Associates
37
T. Rowe Price Associates
Maryland
$5.15M +$487K +36,546 +11%
PP
38
PDT Partners
New York
$4.88M -$1.12M -84,326 -20%
AQR Capital Management
39
AQR Capital Management
Connecticut
$4.83M +$829K +62,175 +22%
AIMCA
40
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$4.69M +$345K +25,900 +9%
SGAM
41
Smith Group Asset Management
Texas
$4.45M +$615K +46,083 +17%
AllianceBernstein
42
AllianceBernstein
Tennessee
$4.4M +$224K +16,810 +6%
GC
43
Guggenheim Capital
Illinois
$4.37M +$1.16M +87,101 +39%
PPA
44
Parametric Portfolio Associates
Washington
$4.12M +$1.22M +91,377 +46%
CAM
45
ClariVest Asset Management
California
$3.99M +$1.63M +122,155 +77%
TCM
46
Tekla Capital Management
Massachusetts
$3.53M
PAMU
47
Pictet Asset Management (UK)
United Kingdom
$3.36M +$674K +50,500 +27%
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$2.86M -$6.67K -500 -0.2%
TAM
49
Tealwood Asset Management
Minnesota
$2.76M +$56.7K +4,253 +2%
GCP
50
GSA Capital Partners
United Kingdom
$2.7M +$1.49M +111,500 +142%

INVA Hedge Fund Activity: Q4 2017 in Review

200 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q4 2017, worth a combined $1.09B — down 4.9% from $1.14B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new INVA positions and 27 closed out — a net gain of 2 holders — while 77 added to existing stakes and 66 trimmed.

The largest buyer was Connor, Clark & Lunn Investment Management (CC&L), adding an estimated $9.46M. The largest seller was Fidelity Investments, cutting an estimated $29.7M.

  • 200 institutional investors held Innoviva (INVA) as of Q4 2017, unchanged from Q3 2017.
  • Funds reported $1.09B of Innoviva stock for Q4 2017, down 4.9% quarter-over-quarter.
  • 29 funds opened new Innoviva positions in Q4 2017 and 27 closed out, a net change of +2 holders.
  • The largest Innoviva buyer in Q4 2017 was Connor, Clark & Lunn Investment Management (CC&L), an estimated $9.46M added.
  • The largest Innoviva seller in Q4 2017 was Fidelity Investments, an estimated $29.7M sold.

Based on aggregated 13F filings for Q4 2017.